Bio-AMD, Inc. (BIAD) shares gain 16% on Friday’s trading session within 9fold 10day average volume. With a tiny market capitalization below $4M and two products ready for the commercialization, BIAD deserves to be added to your watch list. Keep in mind that the Company’s current focus is on securing commercial agreements with major distributors and […]